Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people lose between 0.5 kg and 2 kg in their first week on Mounjaro, though the range is wide and week one is rarely the best week to judge the medicine. The 2.5 mg starter dose is designed to let your body adjust, not to produce the maximum effect — so the appetite shift many people feel strongly tends to build over the first four to eight weeks rather than arriving on day one. Mounjaro (tirzepatide) is a prescription-only weight-management medicine, and a GPhC-registered prescriber assesses suitability before any treatment begins. If you're trying to decide whether private treatment is worth the cost, or wondering why early results vary so much between people, that's exactly what this page covers.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first week on Mounjaro often produces a noticeable drop on the scales, but a meaningful chunk of that is fluid rather than fat. When your appetite falls and you eat less, glycogen stores in the liver partially deplete, and each gram of glycogen holds roughly three grams of water. The scales reflect that shift quickly. It's not a trick, but it does mean week one weight loss tends to taper slightly before the steadier fat-driven losses begin from weeks four or five onwards, and what most people actually lose in their first week on Mounjaro is covered in detail if you want the figures broken down.
SURMOUNT-1, the pivotal trial published in the New England Journal of Medicine, tracked thousands of adults over 72 weeks and recorded average reductions of around 20–21% of body weight at the 15 mg dose. That's a cumulative picture, not a week-one projection. The consistent finding across the trial programme is that losses accelerate as the dose increases, which is exactly why prescribers titrate gradually.
For a fuller breakdown of how weekly averages play out across the full course, the page on average weekly weight loss on Mounjaro covers the data month by month.
Starting weight matters: someone with a higher BMI typically records a larger absolute loss early on, even if the percentage change is similar. Dietary habits in that first week matter too, eating significantly less than usual amplifies the fluid effect described above. Sleep, stress hormones and how much your appetite responds to 2.5 mg all vary between individuals.
The per-week tirzepatide breakdown puts the early numbers in context: the first two months are primarily about tolerability and establishing the habit, not maximising loss. Prescribers at nume watch for this pattern; a modest week one isn't a signal that the medicine isn't working.
NHS guidance on tirzepatide, available via the NHS medicines page, confirms the dose-titration schedule and explains why the starting dose is lower than the therapeutic target, that context is easy to miss if you're only watching the number on the scales.
This is where the decision usually sits: if week one results are modest and the cost is real, is it worth continuing? To answer that honestly, it helps to know exactly what you're paying for.
UK private Mounjaro pricing has changed substantially since Eli Lilly raised its list price in September 2025, with widely reported market prices now ranging roughly £149–£375 per month depending on dose and provider. That spread exists because providers charge differently, and because not all prices include the same things. Some headline figures cover the pen only; consultation fees, prescription charges, delivery costs and clinical aftercare are sometimes extras. Understanding that gap matters more than finding the lowest number.
Our approach at nume is deliberately not the most competitive on price. One amount covers the prescriber consultation, the prescription, the treatment itself, tracked DPD delivery, and access to aftercare seven days a week. No repeat consultation fees, no delivery charges added at checkout. The current price is shown on our Mounjaro pricing page, and a more detailed look at how costs compare appears on the cost breakdown page. We don't run discount codes or promotional offers, and you'll find that upfront rather than buried in the small print.
A small saving each month looks attractive. But Mounjaro is a Prescription-Only Medicine, which means the supply chain and clinical oversight matter in a way they simply don't for a supplement. The MHRA has warned publicly about counterfeit weight-loss pens sold online (some containing insulin rather than tirzepatide) and enforcement actions in 2025 alone involved roughly 20 million doses of illegally traded medicines worth around £45 million. Sellers offering this medicine without a proper prescription and clinical assessment are a red flag, not a deal.
You can verify any online pharmacy's registration on the GPhC register, nume's registration number is 9012878. Every order through us is dispensed from our GPhC-registered pharmacy and reviewed by a named prescriber before dispatch. If timing matters to you (say you want treatment before a holiday or ordered on payday at the end of the month) orders placed by midday Monday to Friday go out the same day once approved, arriving with DPD the next working day. That reliability is part of what the price buys. To see if you're clinically suitable and speak to our prescribers, the consultation is free and takes a few minutes to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.